Fabrice Viviani
Chief Executive Officer chez ONCODESIGN
Profil
Fabrice Viviani is currently the Chief Executive Officer at Oncodesign SA and the President & Chief Executive Officer at Oncodesign Services SA. He previously worked as a Manager-Research & Clinical Project at Aventis SA and as an Associate Vice President-Research & Development at Sanofi-Aventis France SA.
Postes actifs de Fabrice Viviani
Sociétés | Poste | Début |
---|---|---|
ONCODESIGN | Chief Executive Officer | 05/11/2022 |
Oncodesign Services SA
Oncodesign Services SA Miscellaneous Commercial ServicesCommercial Services Oncodesign Services SA is a contract research organization that specializes in drug discovery and preclinical services. The company is based in Dijon, France, and has subsidiaries in Canada. The French company contributes to the development of innovative therapies in oncology, inflammation, and infectious diseases through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vivo/in vitro pharmacology. The company was founded in 1995 by Philippe Genne, and Fabrice Viviani has been the CEO of the company since December 01, 2022. | Chief Executive Officer | 01/12/2022 |
Anciens postes connus de Fabrice Viviani
Sociétés | Poste | Fin |
---|---|---|
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Chief Tech/Sci/R&D Officer | - |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
Oncodesign SA
Oncodesign SA BiotechnologyHealth Technology Oncodesign SA is a biopharmaceutical company, which engages in the provision of solutions for the assessment and validation of anti-cancer therapies. It also offers services in pharmacology, pharmco-imaging, bio-analysis, bio-banking, translational bio-makers, and bio-decontamination. The firm operates through the following business units: Service, Biotech, and Artificial Intelligence. The company was founded by Philippe Genne and Eric Solary on January 17, 1995 and is headquartered in Dijon, France. | Health Technology |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Oncodesign Services SA
Oncodesign Services SA Miscellaneous Commercial ServicesCommercial Services Oncodesign Services SA is a contract research organization that specializes in drug discovery and preclinical services. The company is based in Dijon, France, and has subsidiaries in Canada. The French company contributes to the development of innovative therapies in oncology, inflammation, and infectious diseases through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vivo/in vitro pharmacology. The company was founded in 1995 by Philippe Genne, and Fabrice Viviani has been the CEO of the company since December 01, 2022. | Commercial Services |